Cleared Traditional

Latitud™ Hip Replacement System (K222436) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K222436 · Meril Healthcare Pvt. , Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2023
Decision
270d
Days
Class 2
Risk

K222436 is an FDA 510(k) clearance for the Latitud™ Hip Replacement System. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Meril Healthcare Pvt. , Ltd. (Vapi, IN). The FDA issued a Cleared decision on May 9, 2023 after a review of 270 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Meril Healthcare Pvt. , Ltd. devices

Submission Details

510(k) Number K222436 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 12, 2022
Decision Date May 09, 2023
Days to Decision 270 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
148d slower than avg
Panel avg: 122d · This submission: 270d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 324
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K222436.
OR3O Dual Mobility Liners
K232667 · Smith & Nephew, Inc. · Oct 2023
Mpact Extension
K230011 · Medacta International S.A. · Sep 2023
DePuy 3D Additive TriFlange Acetabular Cup and DePuy TriFlange II Acetabular Cup System
K232556 · Depuy Ireland UC · Sep 2023
LINK MobileLink Acetabular Cup System
K222066 · Waldemar Link GmbH & Co. KG · Apr 2023
BENCOX Mirabo Z Cup Cortinium
K223223 · Corentec Co., Ltd. · Feb 2023
EMPOWR™ blade stem
K223779 · Encore Medical, LLC · Feb 2023